137071-32-0
810.45
C43H68ClNO11
DMSO (25 mg/ml) or EtOH (25 mg/ml)
-20°C
Pimecrolimus is a cell-selective inhibitor of inflammatory cytokines developed for the treatment of inflammatory skin diseases, such as allergic contact dermatitis, atopic dermatitis, plaque-type psoriasis, and irritant contact dermatitis. It reduces the production of inflammatory cytokines in T cells and mast cells and inhibits the release of preformed inflammatory mediators from mast cells.
0.1 lbs
Research or further manufacturing use only, not for food or drug use.
